Markwin VeldersVP Operations at Kite Pharma
Dr. Markwin Velders brings over 18 years of management experience in biotechnology companies.
End of 2013 Markwin became involved with a start up from the Netherland’s Cancer Institute (NKI) that was incorporated in 2014 and called T-cell Factory (TCF). Subsequently, he was instrumental in the M&A deal where Kite Pharma Inc. acquired TCF to form Kite Pharma EU B.V. Since March 2015 he is Vice President Operations and Managing Director of Kite Pharma EU B.V. in Amsterdam.
Markwin is chairman of the board of HollandBio, the branch association for Biotech in the Netherlands and supervisory board member at ISA Pharmaceuticals in Leiden.